A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Clinical trial NCT01525550 · COMPLETED
Trial details
- NCT number
- NCT01525550
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-06
- Primary completion
- 2016-03-19
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.